Medical devices, healthcare technology and the business of care
510(k) clearance · K260133

CADDIE

Odin Medical Limited · Decision date Sep 12, 2026

MEDTECHLEDGER EXPLANATIONK260133

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for CADDIE, a 510(k) submitted by Odin Medical Limited of London, on 12 September 2026; the application was received on 16 January 2026 under regulation 876.1520, product code QNP, in the Gastroenterology/Urology panel. SESE is a clearance, not a PMA approval. The public record lists the device classification as a gastrointestinal lesion software detection system and describes CADDIE as cloud-based artificial intelligence software that interfaces with an endoscopic video feed, limited to standard white-light endoscopy imaging.

The submission is a Special 510(k) addressing the introduction of a new compatible device, Arc Endocuff Vision, with performance testing described in the summary. The record does not state the predicate device, the specific testing results, or any clinical performance measures, so the basis for the equivalence finding beyond the compatible-device change remains unknown from these excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 12, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260133
Regulatory pathway
510(k) premarket notification
Product code
QNP
Decision code
SESE
Decision date
Sep 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gastrointesinal Lesion Software Detection System.

Product code
QNP
FDA device class
2

FDA decision timeline

  1. K260133 received

    Application receipt date recorded by FDA.

  2. K260133 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Odin Medical Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
London

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records